Eighth Annual Controversies in Hematologic Malignancies Symposium
This one-day symposium will raise and address the most challenging questions in current clinical practice for hematologic malignancy. Topics will include Hodgkin lymphoma, TKI's for CML, precision medicine, antifungal prophylaxis, cellular therapy for myeloma, updates in acute leukemia and more.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Pharmacists and Registered Nurses
Learning Objectives
The aim of this conference is to highlight major controversies in the treatment of hematological malignancies. At the completion of this activity, attendees will be able to make therapeutic decisions based on the available data, realizing the ongoing debate in those areas.
7:30-8:20am | Registration/Breakfast/View Exhibits
8:20-8:30am | Introduction
8:30-9:15am | Update in the Management of Hodgkin Lymphoma
Nancy Bartlett, MD, Washington University
9:15-10:00am | Discontinuing TKI's for CML
Ehab Atallah, MD, Medical College of Wisconsin
10:00-10:15am | Break
10:15-11:00am | Cellular Therapy for Myeloma
Adam Cohen, MD, Hospital of the University of Pennsylvania
11:00-11:45am | Breakout Sessions
Hospice Considerations for Hematologists
Mary Rhodes, MD, Medical College of Wisconsin
Antifungal Prophylaxis
Angela Huang, Pharm D, Froedtert Hospital
Management of Anticoagulation During Thrombocytopenia
Lisa Baumann-Kreuziger, MD, Medical College of Wisconsin
11:45-12:45pm | Lunch
12:45-1:30pm |CLL 2019: Exciting New Results Raise Important Issues
Charles Schiffer, MD, Karmanos Cancer Institute
1:30-2:15pm | Updates in Acute Leukemia
Sameem Abedin, MD, Medical College of Wisconsin
2:15-3:00pm | Should Hodgkin Lymphoma Patients That Fail Autotransplant Still Undergo Allogeneic Transplant?
Mehdi Hamadani, MD and Timothy Fenske, MD, Medical College of Wisconsin
3:00pm | Adjourn
Please ask for a complimentary parking ticket at the registration tables on the 5th floor of the Hilton in the Crystal Ballroom. A block of rooms has been reserved at a special rate (single or double occupancy) for the evening of Friday, March 9, 2019. The special room rate will be available under the group name "Medical College of Wisconsin - Hematology" until the group block is sold out.
Guest Speakers
Nancy Bartlett, MD
Koman Chair in Medical Oncology
Professor, Department of Medicine
Washington University School of Medicine
Adam Cohen, MD
Director, Myeloma Immunotherapy
Assistant Professor of Medicine
Hospital of the University of Pennsylvania
Froedtert and the Medical College of Wisconsin Speakers
Sameem Abedin, MD
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Ehab Atallah, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Lisa Baumann-Kreuziger, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Professor of Medicine
Mehdi Hamadani, MD
Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
Angela Huang, PharmD
Froedtert Hospital
Mary Rhodes, MD
Assistant Professor of Medicine
Palliative Care
Medical College of Wisconsin
Planning Committee
Binod Dhakal
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Lyndsey Runaas, MD
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Dan Bullock
Education Program Associate
Division of Hematology and Oncology
Medical College of Wisconsin
Catherine Sestito, APNP
Nurse Practitioner
Division of Hematology and Oncology
Medical College of Wisconsin
Robert Taylor, MD
Director of Autologous Stem Cell Transplant Program
Aurora Cancer Care
Mindy Waggoner, PharmD, BCOP
Oncology Nurse Manager
Pharmacy-Oncology Services
Froedtert Hospital
All persons in control of content have NO relevant financial relationships to dislose with the exception of:
Name | Company | Role |
---|---|---|
Nancy Bartlett, MD | Affimed, Bristol-Myers Squibb, Celgene, Forty Seven, Genentech, Gilead, Immune Design, Janssen, KITE, Merck, Millenium, Pharmacyclics, Seattle Genetics, ADC Therapeutics (Advisory Board), Pfizer (Advisory Board), Acerta (Advisory Board)
| Research Funded
|
Adam Cohen, MD | Celgene Janssen Novartis | Advisory Board Advisory Board Clinical Trial |
Charles Schiffer, MD | Celgene, Pharmacyclics | Advisory Board |
Ehab Atallah, MD | Pfizer, Novartis, Bristol-Myers Squibb and Takeda | Research & Advisory Board |
Angela Huang, PharmD | Merck | Honorarium |
Timothy Fenske, MD | Celgene, Sanofi, Seattle Genetics | Consultant |
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 5.25 hours of participation for continuing education for allied health professionals.
Nurse Practitioners:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930. This program has been approved for 5.25 contact hours of continuing education (which includes 0.75 hours of pharmacology).
Available Credit
- 5.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 5.25 Hours of ParticipationHours of Participation credit.
- 0.75 NP PharmacologyNP Pharmacology credit.
- 5.25 NP Contact Hours